Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongyun Yang

Showing results (71-80 of 159) with videos related to

Pageof 16
Sort By:
Molecular Cancer Therapeutics|October 31, 2013
Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapyYan Ning, Armin Gerger, Wu Zhang, et al.
Cancers|October 17, 2020
Polymorphisms within Immune Regulatory Pathways Predict Cetuximab Efficacy and Survival in Metastatic Colorectal Cancer PatientsNico B Volz, Diana L Hanna, Sebastian Stintzing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Influence of sex on the survival of patients with esophageal cancerPierre Bohanes, Dongyun Yang, Ruchika S Chhibar, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 30, 2020
Reactivation of human herpesvirus 6 in pediatric allogeneic hematopoietic stem cell transplant recipientsAnna B Pawlowska, Nicole A Karras, Huaying Liu, et al.
Leukemia & Lymphoma|December 9, 2021
Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantationAmandeep Salhotra, Dongyun Yang, Sally Mokhtari, et al.
Molecular Cancer Therapeutics|August 1, 2015
Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR ApproachYan Ning, Diana L Hanna, Wu Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2020
Iron Overload Is Associated with Delayed Engraftment and Increased Nonrelapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell TransplantationMonzr M Al Malki, Joo Y Song, Dongyun Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumabAnne M Schultheis, Georg Lurje, Katrin E Rhodes, et al.
Transplantation and Cellular Therapy|May 9, 2022
Long-Term Follow-Up of Multiple Myeloma Patients Treated with Tandem Autologous Transplantation Following Melphalan and Upon Recovery, Total Marrow IrradiationColton Ladbury, George Somlo, Andy Dagis, et al.
Molecular Cancer Therapeutics|March 18, 2016
TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based ChemotherapySatoshi Matsusaka, Wu Zhang, Shu Cao, et al.
Pageof 16

Showing results (71-80 of 159) with videos related to

Sort By:
Pageof 16
Molecular Cancer Therapeutics|October 31, 2013
Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapyYan Ning, Armin Gerger, Wu Zhang, et al.
Cancers|October 17, 2020
Polymorphisms within Immune Regulatory Pathways Predict Cetuximab Efficacy and Survival in Metastatic Colorectal Cancer PatientsNico B Volz, Diana L Hanna, Sebastian Stintzing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Influence of sex on the survival of patients with esophageal cancerPierre Bohanes, Dongyun Yang, Ruchika S Chhibar, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 30, 2020
Reactivation of human herpesvirus 6 in pediatric allogeneic hematopoietic stem cell transplant recipientsAnna B Pawlowska, Nicole A Karras, Huaying Liu, et al.
Leukemia & Lymphoma|December 9, 2021
Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantationAmandeep Salhotra, Dongyun Yang, Sally Mokhtari, et al.
Molecular Cancer Therapeutics|August 1, 2015
Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR ApproachYan Ning, Diana L Hanna, Wu Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2020
Iron Overload Is Associated with Delayed Engraftment and Increased Nonrelapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell TransplantationMonzr M Al Malki, Joo Y Song, Dongyun Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumabAnne M Schultheis, Georg Lurje, Katrin E Rhodes, et al.
Transplantation and Cellular Therapy|May 9, 2022
Long-Term Follow-Up of Multiple Myeloma Patients Treated with Tandem Autologous Transplantation Following Melphalan and Upon Recovery, Total Marrow IrradiationColton Ladbury, George Somlo, Andy Dagis, et al.
Molecular Cancer Therapeutics|March 18, 2016
TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based ChemotherapySatoshi Matsusaka, Wu Zhang, Shu Cao, et al.
Pageof 16